| Melatonin in cancer treatment: current knowledge and future opportunities WH Talib, AR Alsayed, A Abuawad, S Daoud, AI Mahmod Molecules 26 (9), 2506, 2021 | 164 | 2021 |
| Plant-derived natural products in cancer research: extraction, mechanism of action, and drug formulation WH Talib, I Alsalahat, S Daoud, RF Abutayeh, AI Mahmod Molecules 25 (22), 5319, 2020 | 87 | 2020 |
| Plants as a source of anticancer agents: From bench to bedside WH Talib, S Daoud, AI Mahmod, RA Hamed, D Awajan, SF Abuarab, ... Molecules 27 (15), 4818, 2022 | 42 | 2022 |
| Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies S Daoud, SJ Alabed, LA Dahabiyeh Acta Pharmaceutica 71 (2021), 2020 | 35 | 2020 |
| The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan AR Alsayed, W Talib, A Al-Dulaimi, S Daoud, M Al Maqbali Bosnian journal of basic medical sciences 22 (5), 784, 2022 | 20 | 2022 |
| Pharmacophore modeling of JAK1: a target infested with activity-cliffs S Daoud, MO Taha Journal of Molecular Graphics and Modelling 99, 107615, 2020 | 17 | 2020 |
| Ligand-based modeling of CXC chemokine receptor 4 and identification of inhibitors of novel chemotypes as potential leads towards new anti-COVID-19 treatments S Daoud, M Taha Medicinal Chemistry 18 (8), 871-883, 2022 | 13 | 2022 |
| Preparation, physicochemical characterization and biological evaluation of some hesperidin metal complexes S Daoud, FU Afifi, AG Al-Bakri, V Kasabri, II Hamdan Iranian Journal of Pharmaceutical Research: IJPR 13 (3), 909, 2014 | 13 | 2014 |
| Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning MF Al-Tawil, S Daoud, MH Ma'mon, MO Taha RSC advances 12 (17), 10686-10700, 2022 | 11 | 2022 |
| Determination of antimicrobial drug resistance among bacterial isolates in two hospitals of Baghdad I Mahmoud, K Altaif, MA Sini, S Daoud, N Aqel Jordan Journal of Pharmaceutical Sciences 13 (1), 2020 | 11 | 2020 |
| Synthesis, computational, anticancerous and antiproliferative effects of some copper, manganese and zinc complexes with ligands derived from symmetrical 2, 2’-diamino-4, 4 … TS Ababneh, M El-Khateeb, AK Tanash, TMA AL-Shboul, MJA Shammout, ... Polish Journal of Chemical Technology 23 (1), 7-15, 2021 | 7 | 2021 |
| Pharmacophore Modeling of Targets Infested with Activity Cliffs via Molecular Dynamics Simulation Coupled with QSAR and Comparison with other … A Abudayah, S Daoud, MA Al‐Sha'er, M Omar Taha Molecular Informatics 41 (11), 2200049, 2022 | 5 | 2022 |
| Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus S Daoud, S Thiab, T Jazzazi, T Al-Shboul, S Ullah Acta Pharmaceutica 72 (3), 449-458, 2022 | 5 | 2022 |
| Design and synthesis of new JAK1 inhibitors based on Sulfonamide-Triazine Conjugates S Daoud, MO Taha Current Computer-Aided Drug Design 17 (7), 916-926, 2021 | 5 | 2021 |
| Augmenting bioactivity by docking‐generated multiple ligand poses to enhance machine learning and pharmacophore modelling: discovery of new TTK inhibitors as case study AM AL‐Imam, S Daoud, MM Hatmal, MO Taha Molecular Informatics 42 (6), 2300022, 2023 | 3 | 2023 |
| Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes R Banat, S Daoud, MO Taha Molecular Diversity, 1-17, 2024 | 1 | 2024 |
| Assessing health-related behaviors among Jordanian children during COVID-19 pandemic: A cross-sectional study S Thiab, M Barakat, R Qudah, I Basheti, S Daoud Pharmacy Practice 20 (2), 1-8, 2022 | 1 | 2022 |
| Activity Cliffs As Protein-Related Phenomenon: Investigation Using Machine Learning Against Numerous Protein Kinases S Daoud, M Taha | 1 | 2022 |
| Advances in the design and discovery of next-generation janus kinase-2 (JAK2) inhibitors for the treatment of myeloproliferative neoplasms S Daoud, MO Taha Expert Opinion on Drug Discovery, 1-13, 2024 | | 2024 |
| Discovery of novel chemotype inhibitors targeting Anaplastic Lymphoma Kinase receptor through ligand-based pharmacophore modelling I El-Jundi, S Daoud, MO Taha SAR and QSAR in Environmental Research, 1-21, 2024 | | 2024 |
Mutasem TahaProfessor of Drug Design, University of Jordan在 ju.edu.jo 的電子郵件地址已通過驗證
